SKI Market

Indian Indices

Nifty

24,578.35 -346.35
(-1.39%)

Sensex

81,148.22 -1,281.68
( -1.55%)

Bank Nifty

54,940.85 -442.00
( -0.80%)

Nifty IT

37,354.60 -927.95
( -2.42%)

Global Indices

Nasdaq

42,424.12 1,153.74
(2.80%)

Dow Jones

5,865.06 184.15
(3.24%)

Hang Seng

38,283.51 639.25
(1.70%)

Nikkei 225

8,602.92 -2.06
(-0.02%)

Forex

USD-INR

85.41 0.03
(0.03%)

EUR-INR

96.03 -0.26
(-0.27%)

GBP-INR

113.57 0.08
(0.07%)

JPY-INR

0.59 0.00
(-0.40%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Nath Bio-Genes (India) Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

537291

INE448G01010

341.3302463

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATHBIOGEN

7.6

316.04

EPS(TTM)

Face Value()

Div & Yield %

21.89

1.2

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	332.62	301.29	278.36	307.56	279.89	230.93
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	332.62	301.29	278.36	307.56	279.89	230.93
Other Income	4.10	0.56	1.85	1.67	1.82	2.27
Stock Adjustments	19.92	-11.98	-4.99	21.76	48.25	30.46
Total Income	356.64	289.87	275.22	330.99	329.96	263.66
EXPENDITURE :
Raw Materials	11.02	5.31	3.56	8.96	7.35	5.49
Power & Fuel Cost	1.13	1.39	1.07	1.23	1.02	0.95
Employee Cost	27.31	23.23	24.78	23.69	18.74	16.43
Other Manufacturing Expenses	121.72	96.83	114.86	150.17	169.15	132.90
Selling & Administrative Expenses	139.24	112.15	89.94	74.85	75.67	60.86
Miscellaneous Expenses	1.64	1.42	90.67	3.66	1.41	1.39
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	302.07	240.33	324.89	262.56	273.35	218.02
Operating Profit	54.57	49.54	-49.66	68.44	56.61	45.64
Interest	9.19	10.21	10.64	8.87	6.65	5.33
Gross Profit	45.38	39.33	-60.30	59.57	49.96	40.31
Depreciation	3.26	3.01	3.08	2.82	1.45	1.45
Profit Before Tax	42.12	36.32	-63.38	56.75	48.51	38.86
Tax	1.95	1.15	3.95	0.40	-2.01	0.30
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.69	0.03	0.14
Reported Net Profit	40.18	35.17	-67.34	55.66	50.48	38.43
Extraordinary Items	3.29	0.00	-91.12	0.00	0.03	0.00
Adjusted Net Profit	36.89	35.17	23.78	55.66	50.45	38.43
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	-0.08
P & L Balance brought forward	405.84	374.47	445.61	389.95	339.47	301.12
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	3.80	3.80	3.80	0.00	0.00	0.00
P & L Balance carried down	442.21	405.84	374.47	445.61	389.95	339.47
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	20.00	20.00	20.00	20.00	0.00	0.00
Dividend Per Share(Rs)	2.00	2.00	2.00	2.00	0.00	0.00
Earnings Per Share-Unit Curr	21.14	18.50	-35.43	29.29	26.56	20.22
Earnings Per Share(Adj)-Unit Curr	21.14	18.50	-35.43	29.29	26.56	20.22
Book Value-Unit Curr	321.33	301.70	285.19	322.71	293.42	267.09
Book Value(Adj)-Unit Curr	321.33	301.70	285.19	322.71	293.42	267.09

24,578.35 -346.35 (-1.39%)

81,148.22 -1,281.68 ( -1.55%)

54,940.85 -442.00 ( -0.80%)

37,354.60 -927.95 ( -2.42%)

42,424.12 1,153.74 (2.80%)

5,865.06 184.15 (3.24%)

38,283.51 639.25 (1.70%)

8,602.92 -2.06 (-0.02%)

85.41 0.03 (0.03%)

96.03 -0.26 (-0.27%)

113.57 0.08 (0.07%)

0.59 0.00 (-0.40%)